RE:RE:RE:RE:RE:KINLYTIC….FDA approval to go forward ……finally!In case anyone missed it there will be Adelaide session tomorrow which should be very informative. Q4 2023 results will come soon and will be a new record. Q1 2024 fiscal will be indicative of the ongoing transformation of this hilariously undervalued company (do some calculations of expected annual royalty payments for US market and then add Europe and compare to todays market cap). This situation won't last long now that FDA answer is in.